It's #cannabis earnings season, and CEOs are answering questions about federal reform under Trump. Read the latest Cultivated Daily in the comments below, from Jeremy Berke.
It's earnings season for many US publicly traded #cannabis firms, and of course, execs are answering questions about the prospects of federal reform under Trump 47. Despite having access to the same sources of information, they seem to be arriving at wildly different conclusions: Florida-based Trulieve CEO Kim Rivers says she's "optimistic," that the Administration will pursue industry-friendly reform, including normalized tax rates and banking access, but stopped short of legalization. Chicago-based Green Thumb Industries CEO Ben Kovler thinks the exact opposite: "We’ve seen things differently from our peers for a long time.... And we are not optimistic about changes in DC. Look at the appointees and look at Kennedy’s (RFK JR’s) total 180. So instead, we’re going to play offense… We think the people in DC are out to lunch." And Verano CEO George Archos landed somewhere in the middle. So what explains the difference? Well, for one, most of the industry prognostication over federal reform is pure speculation based on a few of Trump's social media posts. It's clear cannabis was never a day one initiative. Two, it's another sign that the industry should focus on profitability and controlling what it can control under the current regulatory environment. Read the latest Cultivated Media in the comments below.